BioMed Research International / 2015 / Article / Tab 3

Research Article

Acute and Chronic Toxicity, Cytochrome P450 Enzyme Inhibition, and hERG Channel Blockade Studies with a Polyherbal, Ayurvedic Formulation for Inflammation

Table 3

(a) Serum chemistry in rats treated with BV-9238 (male) for chronic toxicity studies. (b) Serum chemistry in rats treated with BV-9238 (female) for chronic studies.
(a)

Dose Group IGroup IIGroup IIIGroup IV
Vehicle control1 g/kg/d2 g/kg/d2 g/kg/d

Total plasma protein (g%)
AST (IU/L)
ALT (IUL)
Blood urea (mg/dL)
Alk. phos. (IUL)
Blood glucose (mg/dL)
Cholesterol (mg/dL)
Triglycerides (mg/dL)

Values are expressed as mean and standard deviation. Values are nonsignificant when compared with Group I (control) animals.
(b)

Dose Group IGroup IIGroup IIIGroup IV
Vehicle control1 g/kg/d2 g/kg/d2 g/kg/d

Total plasma protein (g%)
AST (IUL)
ALT (IUL)
Blood urea (mg/dL)
Alk. phos. (IUL)
Blood glucose (mg/dL)
Cholesterol (mg/dL)
Triglycerides (mg/dL)

Values are expressed as mean and S.D. Values are nonsignificant when compared with Group I (control) animals.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.